protocol bpc 157 BPC-157 Dosage Protocol: Injection Guide BPC 157: Science-Backed Uses, Benefits,

intramuscular administration Subcutaneous (into fatty tissue of abdomen, typically 1-2 inches lateral to navel, using a 25-27 gauge, 5/8-inch needle): 28% report injection-site soreness Easier for self-administration Slower absorption (peak serum B12 at 12-18 hours vs

In rodent models of inflammatory bowel disease, oral BPC-157 treatment was associated with reduced colonic inflammation, accelerated mucosal healing, and improvement in disease activity scores

Indicated Cases This formulation is most appropriate for: Adult cats 2.55 kg with FIP presenting alongside anaemia (confirmed by haematology or suspected clinically) Wet FIP cases with concurrent lethargy and appetite suppression disproportionate to effusion severity Dry FIP cases with systemic involvement and immune compromise Cases where owner or veterinarian wishes to consolidate daily antiviral injection with B12 supplementation Cats on concurrent medications that may affect appetite or GI absorption This Formulation Is Not the First Choice For Cats requiring therapeutic-dose B12 at intervals other than once daily maintain a separate B12 protocol as directed by your veterinarian Cats outside the 2.55 kg weight range select the appropriate concentration for your cat's weight Cats with no secondary systemic complications the standard 30mg/ml formulation is sufficient Concentration Selection Guide Administration Administer subcutaneously once daily

The effects of our shots vary between individuals

Quick Takeaways BPC-157 is a mechanistically compelling peptide with strong animal data on healing, inflammation, and neuroprotection Both injectable and oral forms of BPC_157 have well-established real-world utility, and are the only proven paths for experiencing the real healing benefits of BPC-157 Nasal spray bioavailability for BPC-157 is poor, a consistent observation of experienced clinicians and self-experimenters No human clinical trials exist for BPC-157 in any delivery format, including the nasal spray Intranasal delivery is theoretically interesting for CNS access, but specifically remains unvalidated when it comes to BPC-157 What Is BPC-157